Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Chinese patent medicine Tongxinluo capsule (TXL) is commonly used for cardio-cerebrovascular diseases. Previous research had demonstrated that TXL exhibited great clinical effects on the treatment of acute myocardial infarction (AMI), however there is a lack of systematic review. The pur...

Full description

Bibliographic Details
Main Authors: Min Li, Chengyu Li, Shiqi Chen, Yang Sun, Jiayuan Hu, Chen Zhao, Ruijin Qiu, Xiaoyu Zhang, Qin Zhang, Guihua Tian, Hongcai Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Pharmacology
Subjects:
tongxinluo
TXL
acute myocardial infarction
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.00830/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.00830/full

Similar Items